Search results
The Centers for Disease Control and Prevention (CDC) has recently updated COVID-19 quarantine and isolation recommendations for healthcare and non-healthcare settings. During this COCA Call, presenters will discuss the science supporting these changes, the populations and settings to which these changes apply, and additional precautions people ...
Date: Thursday, January 13, 2022 Time: 2:00 PM – 3:00 PM EST The Centers for Disease Control and Prevention (CDC) has recently updated COVID-19 quarantine and isolation recommendations for healthcare and non-healthcare settings. During this COCA Call, presenters will discuss the science supporting these changes, the populations and settings ...
Updates to CDC COVID-19 Healthcare Guidance. Alex Kallen, MD, MPH. Chief, Prevention and Response Branch Division of Healthcare Quality Promotion Centers for Disease Control and Prevention. January 13, 2022 Clinician Outreach and Communication Activity Call. Recent CDC healthcare guidance updates. December 23, 2021.
- 1MB
- 68
- Overview
- CURRENT COVID-19 Vaccine Recommendations
- ARCHIVED COVID-19 Immunization Publications
See Clinical Considerations for Use of COVID-19 Vaccines
•MMWR, October 20, 2023, Vol 72(42);1140–1146
Use of Updated COVID-19 Vaccines 2023–2024 Formula for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2023
•Print version [7 pages]
•See also:
•Grading of Recommendations, Assessment, Development, and Evaluation (GRADE): Updated COVID-19 vaccine (2023-2024 Formulation) | CDC
•EtR framework for Use of an Updated (Monovalent XBB Containing) COVID-19 Vaccine Under an Emergency Use Authorization | CDC
For your convenience, these archived publications can be used for historical and research purposes.
•MMWR, June 16, 2023, Vol 72(24);657–662
Interim Recommendations for Use of Bivalent mRNA COVID-19 Vaccines for Persons Aged ≥6 Months — United States, April 2023
•Print version [6 pages]
•MMWR, November 11, 2022, Vol 71(45); 1436-1441
Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines — United States, October 2022 | MMWR (cdc.gov)
Mar 15, 2024 · Headache. New loss of taste or smell. Sore throat. Congestion or runny nose. Nausea or vomiting. Diarrhea. This list does not include all possible symptoms. Symptoms may change with new COVID-19 variants and can vary by person. CDC will continue to update this list as we learn more about COVID-19.
Oct 4, 2023 · Hundreds of millions of people in the United States have safely received COVID-19 vaccines. CDC and FDA continue to provide updated information on the safety of U.S. authorized or approved COVID-19 vaccines using data from the Vaccine Safety Datalink (VSD), Vaccine Adverse Event Reporting System (VAERS), and other safety monitoring systems.
